Current Clinical Trials

Department: Oncology
Diagnosis: Gastrointestinal - Colon-Rectal
Principal Investigator: Lowry MD, Philip
Sub-Investigator(s):
Sponsor: CALGB
Indentifier #: NCT01150045
Title: CALGB 80702, A Phase III Trial of 6 Versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients With Resected Stage III Colon Cancer
Department: Oncology
Diagnosis: Gastrointestinal - Liver
Principal Investigator: O'Brien M.D., Edward Thomas
Sub-Investigator(s):
  • Cianfoni CCRP, Michelle
Sponsor: CALGB
Indentifier #: NCT01015833
Title: CALGB 80802, Phase III Randomized Study of Sorafenib Plus Doxorubicin Versus Sorafenib In Patients with Advanced Hepatocellular Carcinoma (HCC)
Department: Oncology
Diagnosis: Gynecology
Principal Investigator: Lynch MD, Cynthia A.
Sub-Investigator(s):
Sponsor: CTSU -NCI
Indentifier #: NCT01366183
Title: GOG-0273, Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Department: Oncology
Diagnosis: Lung- Non-Small Cell
Principal Investigator: Lash MD, Bradley
Sub-Investigator(s):
Sponsor: ECOG
Indentifier #: NCT01107626
Title: E5508, Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC
Department: Oncology
Diagnosis: Melanoma
Principal Investigator: O'Brien M.D., Edward Thomas
Sub-Investigator(s):
Sponsor: ECOG
Indentifier #: NCT01274338
Title: E1609, A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon Alpha-2b for Resected High-risk Melanoma
Department: Oncology
Diagnosis: Lung- Non-Small Cell
Principal Investigator: O'Brien M.D., Edward Thomas
Sub-Investigator(s):
Sponsor: ECOG
Indentifier #: NCT00324805
Title: E1505, A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (> 4 cm) -IIIA Non-Small Cell Lung Cancer (NSCLC)
Department: Oncology
Diagnosis: Oncology - General
Principal Investigator: O'Brien M.D., Edward Thomas
Sub-Investigator(s):
Sponsor: CTSU -NCI
Indentifier #: NCT00588770
Title: E1305, A Phase III Randomized Trial of Chemotherapy with or without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer
Department: Oncology
Diagnosis: Hematology- Lymphoma
Principal Investigator: Srivatana M.D., Panit
Sub-Investigator(s):
Sponsor: Allos
Indentifier #: NCT01110733
Title: COMPLETE Registry, Prospective, Longitudinal, Multinational Registry of Patients With Newly Diagnosed Peripheral T-Cell Lymphoma
Department: Oncology
Diagnosis: Genito-urinary - Miscellaneous
Principal Investigator: O'Brien M.D., Edward Thomas
Sub-Investigator(s):
Sponsor: CALGB
Indentifier #: NCT00942331
Title: CALGB-90601 A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, And Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma

Pages